<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>79(11)</volume><submitter>Bottemanne H</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>Clinical research has shown that persistent negative beliefs maintain depression and that subanesthetic ketamine infusions induce rapid antidepressant responses.&lt;h4>Objective&lt;/h4>To evaluate whether ketamine alters belief updating and how such cognitive effects are associated with the clinical effects of ketamine.&lt;h4>Design, setting, and participants&lt;/h4>This study used an observational case-control protocol with a mixed-effects design that nested 2 groups by 2 testing time points. Observers were not blinded. Patients with treatment-resistant depression (TRD) and healthy volunteer participants aged 34 to 68 years were included. Patients with TRD were diagnosed with major depressive disorder or bipolar depression, had a Montgomery-Åsberg Depression Rating Scale score grea</pubmed_abstract><journal>JAMA psychiatry</journal><pagination>1124-1132</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9520441</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Evaluation of Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression.</pubmed_title><pmcid>PMC9520441</pmcid><pubmed_authors>Claret A</pubmed_authors><pubmed_authors>Fossati P</pubmed_authors><pubmed_authors>Schmidt L</pubmed_authors><pubmed_authors>Bottemanne H</pubmed_authors><pubmed_authors>Sharot T</pubmed_authors><pubmed_authors>Morlaas O</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluation of Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression.</name><description>&lt;h4>Importance&lt;/h4>Clinical research has shown that persistent negative beliefs maintain depression and that subanesthetic ketamine infusions induce rapid antidepressant responses.&lt;h4>Objective&lt;/h4>To evaluate whether ketamine alters belief updating and how such cognitive effects are associated with the clinical effects of ketamine.&lt;h4>Design, setting, and participants&lt;/h4>This study used an observational case-control protocol with a mixed-effects design that nested 2 groups by 2 testing time points. Observers were not blinded. Patients with treatment-resistant depression (TRD) and healthy volunteer participants aged 34 to 68 years were included. Patients with TRD were diagnosed with major depressive disorder or bipolar depression, had a Montgomery-Åsberg Depression Rating Scale score grea</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-18T20:40:06.987Z</modification><creation>2025-04-07T08:44:35.414Z</creation></dates><accession>S-EPMC9520441</accession><cross_references><pubmed>36169969</pubmed><doi>10.1001/jamapsychiatry.2022.2996</doi></cross_references></HashMap>